Being aware of the way your compound interacts with bone and joint cells can be very important to evaluate its efficacy and to design other preclinical studies, especially in choosing the right animal specie(s) and model(s) then.
Atlantic Bone Screen relies on a highly qualified Team and state-of-the-art technical platform to evaluate the in-vitro efficacy, osteogenesis and cytotoxicity of your drug candidates, nutraceuticals, biomaterials or medical devices:
– Screening of potential compounds
– Characterization of the therapeutic effect
– Characterization of the action mechanism
See more on our in-vitro assays:
